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234 The Journal of Thoracic and Cardbjective: This study aimed to test the distribution of intramyocardially injected
ells in variations in heart status in a porcine model of myocardial infarction.
ethods: Bone marrow–derived mesenchymal stem cells were obtained from male
wine and labeled with iron oxide during culture. One week after creation of a
yocardial infarction in female swine, the survivors were randomly divided into 4
roups. Cardiopulmonary bypass was set up to arrest the heart, and then labeled
ells (1  108) were intramyocardially injected into the border zone of the infarcted
one in group 1 (n 6). The same volume of cells was grafted into the beating heart
n group 2 (n  6). In groups 3 and 4, saline was injected in either the arresting or
eating heart. Three days later, cell distribution was assessed by T2* change with
agnetic resonance imaging and sex-determining region on Y-chromosome (SRY)
ith quantitative polymerase chain reaction.
esults: The cells were identified in the heart, spleen, lung, and liver. Most injected
ells were localized in the myocardium in groups 1 and 2; however, the amount of
ells was much higher in group 1 (T2* change: 22.3 2.2 vs 17 0.84; SRY gene:
.15  0.062 vs 0.072  0.003).
onclusions: Even after intramyocardial injection, many cells migrated to extracar-
iac organs, especially to the spleen. Our results indicated that injection in the
rresting heart could favor retaining more cells in the myocardium. Thus, it was an
ptimal approach to deliver mesenchymal stem cells during open chest surgery.
tem cell therapy has emerged as a promising approach for the treatment of
myocardial infarction (MI). The delivery approaches play a critical role in the
process of supplying exogenous cells for replacing and repairing damaged
eart tissue. Intracoronary infusion of freshly isolated bone marrow (BM)-derived
ononuclear cells has been attempted in many clinical trails since 2002.1 Recently,
series of randomly designed studies confirmed the safety and feasibility of this
pproach; however, it also showed that such an uncultured cell therapy could have
o effect or contribute to only mild improvement of heart function.2 There is no
oubt that the process of purification and proliferation would increase the amounts
f progenitor cells and thus improve the efficiency of cell therapy. However,
ntracoronary infusion of cultured cells could result in embolism of the coronary
ystem and cause microinfarction.3
Intramyocardial delivery into the target area can be achieved by transendocardial
nd transepicardial routes. Intramyocardial injection (IMI) could be hybrided with
pen-chest coronary surgery, and, thus, it became one of the convenient approaches
y which cardiac surgeons could deliver the cells. Besides the delivery routes, the
eart status could also affect the migration and actual fate of implanted cells.
owever, to date, little is known about the relation between cell distribution and
iovascular Surgery ● November 2007
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Peart status. Therefore, this preclinical study tested the
istribution of the cultured BM mesenchymal stem cells
MSCs) with IMI in both the arresting and the beating heart
n a porcine MI model.
aterials and Methods
he study was performed in accordance with the guidelines of the
Regulation to the Care and Use of Experimental Animals” (1996)
f the Beijing Council on Animal Care. Chinese miniature swine
ame from the China Agricultural College. All animal experimen-
al procedures were approved by the Ethics Committee for Animal
tudy in Fu Wai hospital.
SC Preparation
M was aspirated from the iliac crest of male swine. A standard
rotocol was then used to obtain the MSCs, as previously de-
cribed.4 MSCs were expanded with 4 to 5 passages and yielded
dequate cells for transplantation.
ell Labeling
onfluent cells were incubated with a mixture of superparamag-
etic iron oxide (SPIO; Resovist, Germany) (50 g/mL) and
oly-L-lysine (400 ng/mL; Sigma Chemical Co, St Louis, Mo) for
8 hours before cell transplantation, as previously described.5 The
iability of the labeled cells was evaluated by trypan blue exclu-
ion test and the labeling efficiency was measured by Prussian blue
taining.
reation of Animal MI Model and Groups
wenty-seven female swine (25–35 kg) were included in the study.
n occlusive angioplasty balloon was advanced into the proximal
eft anterior descending coronary artery via a percutaneous ap-
roach. Acute MI was induced by inflating the balloon for 90
inutes followed by artery perfusion.6
Seven days after MI, the surviving animals were randomly
ssigned to 4 groups: cell transplantation in the arresting heart
group 1, n  6), cell transplantation in the beating heart (group 2,
 6), saline injection in either the arresting or the beating heart
groups 3 and 4, n  6, respectively).
reparation for Cardiopulmonary Bypass and
ithdrawal
ystemic heparinization was performed at 300 IU/kg body weight.
Abbreviations and Acronyms
BM  bone marrow
IMI  intramyocardial injection
MI myocardial infarction
MRI magnetic resonance imaging
MSCs mesenchymal stem cells
qRT-PCR quantitative real-time polymerase chain
reaction
SRY  Y-chromosome geneollowing the institute’s protocol for preparing cardiopulmonary b
The Journal of Thoracicypass, the chest was opened, the arterial cannula was inserted into
he aorta, and a dual-stage atriocaval cannula was placed in the
ight atrium. Then the ascending aorta was clamped and the
ardioplegic solution was perfused to induce cardiac arrest. After
he cell transplantation or saline injection, the body temperature
as rewarmed and the aortic clamp was released. Generally, the
eart would beat again in sinus rhythm.
ell Transplantation
even days after the creation of the MI model, the chest was
pened through the left second intercostal space. After the identi-
cation of the borderline area of MI zone, the labeled MSCs in
uspension (2 mL, 1.0  108 cells) were injected into 4 sites (0.5
L in every site), with marked sutures left to seal the puncture
ole. The needles were punctured at an oblique angle to prevent
he cells from being injected into the ventricular cavity; further-
ore, the injection was started only after making sure no blood has
een sucked back to the syringe.
The same volume of saline was injected in the same way in the
ell transplantation groups.
agnetic Resonance Imaging Study
ll animals underwent magnetic resonance imaging (MRI) 24
ours before cell transplantation or saline injection and then again
2 hours after the procedure. The MRIs were acquired with the
vanto 1.5-T MR scanner (Siemens AG, Berlin, Germany).
Myocardial iron deposition could be quantified by myocardial
2* in the signal void region. T2* is related to T2 by summation
f tissue relaxation (T2) and magnetic inhomogeneity (T2 prime,
2=), and T2* sequence had a greater sensitivity to iron deposition
han T2 sequence. Each scan included the measurement of heart,
iver, spleen, and kidney T2*. For the measurement of myocardial
2*, MRI was performed at multiple time points using fast gra-
ient echo pulse sequences (flip angle 35°, matrix 128  256
ixels, field of view 30 cm, sampling bandwidth of 810 kHz) in
tandard segmented, electrocardiogram-gated, and breath-held ex-
minations.7 In vivo T2* relaxation rates were determined by
ated fast gradient echo with multiple echo times (1.89-20.9 ms).
gating delay time of 0 ms after the R-wave was chosen to obtain
yocardial images in a consistent position in the cardiac cycle
rrespective of the heart rate. A region of interest in the anterior left
entricular wall that is distant from the cardiac veins was mea-
ured. For image signal analysis, we used in-house designed soft-
are (CMR tools, Imperial College, London, United Kingdom).
The liver, spleen, and kidney T2* were determined as standard
rotocol.8 The same imaging protocols as those used for imaging
he heart were used. A large region of interest was chosen in a
omogeneous area of parenchyma without blood vessels.
issue Harvest and Immunohistochemical
xamination
he animals were humanely killed after postoperative MRI study.
bout 2-cm square heart tissues were collected in each of the
njection sites. The harvested tissues were dissected into two
ieces. One was frozen in liquid nitrogen until DNA extraction for
uantitative analysis of male cells with quantitative real-time poly-
erase chain reaction (qRT-PCR) test. Another was paraffin em-edded for Prussian blue staining. The remote noninfarcted myo-
and Cardiovascular Surgery ● Volume 134, Number 5 1235
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CSPardium and the infarcted myocardium were also harvested and
andled in the same way.
Samples of the lung and liver were taken from central locations
nd from the edge of each lobe. Spleen samples were taken from
entral locations and edge tissue. Kidney samples were taken from
ortex and medulla tissue. Each sample was 2-cm square and
reated in the same manner as heart tissue.
The samples from heart and spleen were chosen for immuno-
istochemical examination to detect macrophages (Calprotectin
b-1; Lab Vision Corporation, Fremont, Calif).
RT-PCR
RT-PCR with the ABI Prism 7700 Sequence Detection System
as used to quantify donor male swine cells. It was performed
ith SYBR-Green (Applied Biosystems, Foster City, Calif). The
enomic DNA taken from male MSCs was used to obtain a
tandard curve. The forward primer was AAAGCGGACGATTA-
AGC and the reverse primer was TTTGCATTTGAGGGTTCT.
he RT-PCR protocol consisted of an initial step at 94°C for 2
inutes, followed by 38 cycles: 94°C for 30 seconds’ denatur-
tion, annealing at 50°C for 30 seconds, and elongation at 72°C for
0 seconds.9
To obtain a standard curve, we extracted genomic DNA of
SCs and measured the concentration by spectrophotometry. A
ample was diluted to produce samples, which had a range from 1
g/L to 1 104 g/L concentration. A serial 10-fold dilution
f the DNA from male swine MSCs was tested 5 times in separate
xperiments.
The numbers of implanted male cells in tissues were evaluated
y RT-PCR amplification of the male cell–specific sex-determin-
ng region on Y-chromosome (SRY) gene. The numbers of the
mplanted male cells residing in the myocardium, lungs, liver,
idney, and spleen were compared.
tatistical Analysis
ll values were reported as means  SEM. SPSS Software for
indows (version 10.0; SPSS, Inc, Chicago, Ill) was used for
nalysis.
Differences in organ T2* change of 4 groups were compared by
he least-significant difference (LSD) 1-way analysis of variance
est. Unpaired t test was performed to compare the SRY gene
xpression between different groups.
esults
ortality
hree pigs died of ventricular arrhythmia, which occurred
uring the creation of MI, and 3 died owing to the failure of
reparation of cardiopulmonary bypass in our early series.
hese animals were excluded from the final analysis.
yocardial Images and T2* Change
n MRI visualization of myocardium with a short-axis slice
f mid-left ventricle, signal void corresponding to the in-
ection sites were seen in groups 1 and 2 (Figure 1, a and b).
here was no significant difference in T2* change between
roups 3 and 4. Heart T2* change of the cell transplantation
roups was significantly higher than that of control groups. c
236 The Journal of Thoracic and Cardiovascular Surgery ● Novroup 1 had a higher T2* change than group 2 in the heart
22.3  2.2 vs 17.00  0.84; P  .008) (Figure 1, c).
T2* changes of the cell injection groups were signifi-
antly higher than those of the control groups in the liver
nd spleen (P  .05), but there was no statistical differ-
nce in the kidney (P  .05) (Figure E1). Group 1 had
ess T2* change in the spleen than did group 2 (7.7 
.73 vs 13.28  1.14; P  .001) (Figure 1, c).
The MI area and heart function were also compared, but
e did not observe any differences among any groups
Table E1).
RT-PCR for SRY Gene
n groups 3 and 4, no SRY gene was detected in any tissues.
n groups 1 and 2, many more male cells were detected in
he heart and spleen than those found in other organs.
urthermore, compared with group 2, group 1 has higher
ale cell retention in the myocardium (0.150  0.062 vs
.072  0.004; P  .001) and less retention in the spleen
0.131  0.001 vs 0.233  0.017; P  .001) (Figure 2). In
he noninfarcted myocardium, no male cells were detected
n any cell transplantation group.
In the liver, group 1 had higher cell retention than group
(0.017  0.0009 vs 0.009  0.0005; P  .001), but
here was no statistically significant difference in the lung
0.0015  0.0009 vs 0.0016  0.0009; P  .05). We did
ot detect any implanted male cells in the kidney.
istologic Analysis
n the cell transplantation groups, the implanted cells mostly
ocalized in the injection site. No injected cell was identified
n the remote noninfarcted myocardium and only few Prus-
ian blue-positive cells could be found in the infarcted
yocardium. Compared with group 2 (Figure 3, b), there
re more clustered cells in the border zone of MI in group
 (Figure 3, a).
Except for the heart, the spleen had more Prussian blue-
ositive cells than had any other organ in both cell trans-
lantation groups, and they were mainly distributed in the
ed pulp; furthermore, group 2 (Figure 3, d) had much more
russian blue-positive cells than group 1 (Figure 3, c).
The Prussian blue-positive cells were detected in hepatic
inusoid around the central vein of the hepatic lobule (Fig-
re 3, e). It was relatively hard to find the positive cells in
he lungs, and only a few cells were detected over the
ulmonary interstitial substance, blood vessel side, and in-
erlobular septum (Figure 3, f). We did not find any positive
ells in the kidney in any cell transplantation groups. No
ositive cells were identified in any organs in any of the
ontrol groups.
Although macrophages were presented in infarcted myo-
ardium and spleen, the majority of Prussian blue-positive
ember 2007
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Pells had not been double stained with Calprotectin Ab-1
Figure 3, g and h).
iscussion
M-derived MSC has been demonstrated to be a suitable
ell resource for regenerative purposes for treating MI.10
hen and his colleagues11 infused autologous MSCs into
he coronary arteries for patients with acute MI. Although
o additional microinfarction was observed in Chen’s study,
ransplantation of such large cells through the coronary
rtery still has the great potential for microembolization.
he direct IMI route of administration of MSCs could be the
asiest and most effective way for cardiac surgeons while
hey perform operations such as coronary artery bypass
rafting. From the surgeon’s view, the impact of beating
off-pump) or arrested (on-pump) coronary surgery on the
ell redistribution would be an important issue. Therefore,
n this study, 3 days after cell IMI, we investigated the body
istribution of the injected cells; furthermore, the influence
f variations in heart status for cell distribution was studied.
The major findings in this preclinical model are that (1)
he majority of the transplanted MSCs were retained in the
njection site, (2) although the cells were injected intramyo-
Figure 1. Magnetic resonance visualization of myocard
The dark arrow indicates the signal void correspondi
showed weaker signal void than group 1 (c). (T2* chaardially, they also migrated to other organs, especially to t
The Journal of Thoraciche spleen, and (3) the arresting heart could favor retaining
ore injected cells in the myocardium.
MRI has been proposed as a novel noninvasive approach
o track the iron-labeled transplanted cells in vivo.12 Besides
RI, nuclear medical technologies such as positron emis-
ion tomography were also widely used to describe the cell
ody distribution. However, owing to the short half-life of
he radioactive marker, the nuclear scintigraphic tracking
ight degrade dramatically during the first 24 hours.13 We5
ave confirmed the SPIO was a safe and efficient marker for
he relative long-term cell tracking in the injured myocar-
ium. MRI could offer the high spatial resolution of labeled
ell location and the T2* value could also be compared for
he quantification of implanted cells. SPIO signal could be
diluted” if cells divide; however, in the early stage of cell
ransplantation, the grafted cells would face the challenge
rom the new environment and strive to survive rather than
roliferate. Hence, in this study we did not believe that the
dilution effect” would be a confounding factor. However,
ome factors, including the hemorrhage caused by reperfu-
ion injury, might bias the results of cell distribution.14
herefore, together with MRI analysis, we also used the
RT-PCR as an established method for accurate and sensi-
and the comparison of T2* change in different organs.
the injection sites in groups 1 (a) and 2 (b). Group 2
T2*pre-cell transplant  T2*post-cell transplant).ium
ng to
nge ive quantification for implanted cells. qRT-PCR was first
and Cardiovascular Surgery ● Volume 134, Number 5 1237
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CSPntroduced to evaluate the donor male leukocyte survival in
emale recipients.15 Yasuda and his colleagues9 applied
RT-PCR to study the implanted cell survival in a rat MI
odel. In our study, the results of qRT-PCR were consistent
ith the MRI findings.
Locally direct IMI was more site specific with less sys-
emic engraftment than other delivery approaches.16 How-
ver, the locally injected cells still migrated to extracardiac
rgans. Hou and his colleagues17 found that even after
ntramyocardial injection, most peripheral blood mononu-
lear cells would be trapped in the lung. Owing to the small
ell size, the mononuclear cells could be drained into myo-
ardial veins or lymphatics and then migrate to the right
entricle and lung. Our results were similar to those re-
orted by the researchers who injected the cells directly into
he left ventricular cavity.18 In the study by Barbash and
ssociates,18 after cell infusion in the left ventricle, lung
rapping was bypassed and more cells were trapped in the
pleen and liver. Considering the above observations, we
ypothesized that the injected MSCs would mostly be
rained through the collateral channels and ventricular lu-
en in the borderline area of the MI and then arrive at the
eft ventricle. Finally, the cells were pumped into the aorta
nd resided in the spleen and liver. Furthermore, we found
hat most of the Prussian blue-positive cells in the spleen
ere negative for the macrophage marker Calprotectin
igure 2. RT-PCR amplification of the transplanted male cell-
pecific SRY gene in selected sample from different organs after
ell transplantation. RT-PCR, Real-time polymerase chain reac-
ion; SRY, Y-chromosome gene.b-1, which suggested they were originally injected MSCs. f
238 The Journal of Thoracic and Cardiovascular Surgery ● NovBesides the leaked cells, we found that the majority of
ells still settled at the sites of injection. No cells were found
n the remote noninfarcted myocardium and only a few cells
homed” to the center of myocardial scar tissue. This sug-
ested that the local MSCs responded to the injury signal
nd migrated to the damaged myocardium. However, owing
o the large cell size and different expressed adhesion mol-
cules, only a very small number of MSCs could move to
he remote infarcted myocardium.
In the ongoing clinical trials performed by the surgeons,
ither BM-derived CD133 cells or cultured myoblasts
ere injected into the borderline area of MI under car-
ioplegic arrest.19,20 Teng and her colleagues21 injected the
icrospheres and found the massive mechanical loss by
queezing the microspheres out of the myocardium while
he heart was beating. In our study, IMI in the arresting
eart helped more cells reside in the myocardium. Interest-
ngly, an inverse relationship between the numbers of cells
hat were detected in the heart and spleen was observed.
ince the purse-string suture was placed on the epicardium
o seal the puncture hole in each cell transplantation group,
he backward leakage could be similar between the beating
nd arresting heart. We presumed that the myocardial con-
ractile force augmented the washout of injected cells to the
eft ventricular cavity and thus decreased the number of
ells in the myocardium. Hence, for a patient receiving cell
ransplantation and coronary surgery, on-pump techniques
nd a motionless myocardium were critical for the preven-
ion of excess cell loss in the heart. On the other hand, we
eeded to do more studies to clarify the role of systemic
lter organs in the cell redistribution for the improvement of
fficiency of IMI.
There are some limitations in the present study. First, we
nly studied the early phase of cell body distribution. Ultra-
arly and late dynamic imaging of transplanted cells will be
ecessary in our future study. Second, although we followed
he same protocol as Yasuda and his colleagues9 to evaluate
he number of male cells in different organs, we did not
eport the number and percentage of retained cells in each
rgan. In Yasuda’s study, the experimental model was the
at. Owing to the smaller animal size, the entire organs were
arvested and prepared for qRT-PCR study. In the present
tudy, it was impossible to extract DNA from all parts of
issues from the swine heart or any other extracardiac organ.
herefore, we only selected a typical tissue sample from
very organ and failed to report the percentage relative to
he initial number of injected cells. Third, the myogenic
ifferentiation of grafted cells was usually identified several
eeks after cell injection.22 Thus it would be very difficult
o find the evidence of differentiation and improved heart
unction in the present study. However, the impact of vari-
tions in heart status on differentiation of MSCs and heart
unction would be evaluated in the future long-time study.
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Pinally, the allogenic male MSCs were used as a cell resource
n this study. Although MSCs are supposed to be immune-
rivileged22 and we did not find CD3-positve T lymphocytes
data not shown), a few macrophages were scattered in in-
arcted myocardium, which suggested the mild immune rejec-
ion could exist in this sex-mismatched study. h
The Journal of ThoracicIn conclusion, this preclinical study for the first time
lucidated cell cardiac and extracardiac distribution after
he IMI of MSCs. Furthermore, we found that the arrest-
ng heart during the injection could help more cells reside
n the myocardium. We believe that these results also
Figure 3. Identification of the Prussian
blue-positive cells in different organs
after cell transplantation. The positive
cells were mostly localized in the myo-
cardium and spleen. However, more
cells could be detected in the myocar-
dial injection sites and fewer cells in
the spleen in group 1 (a and c). Fewer
positive cells could be found in the
liver and lung (e and f). Calprotectin
Ab-1 staining showed most of the Prus-
sian blue-positive cells in the heart
(g) and spleen (h) had not originated
from macrophage. (Black arrow indi-
cated the Prussian blue-positive cells;
red arrow indicated the Calprotectin-
positive macrophage.)ave important implications for other exogenous cultured
and Cardiovascular Surgery ● Volume 134, Number 5 1239
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CSPtem cells, including embryonic stem cells, in future
linical trials.
We thank Dr Minjie Lu for assistance in the MRI analysis and
r Chong Shen for assistance in statistical analysis.
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CS
PFigure E1. MRIs of spleen and kidney. The spleen had stronger signal void after cell injection. There was nosignificant difference in T2* change of the kidney in both groups. Compared with group 1, T2* change of spleen
in group 2 was higher. (Arrows represent spleen and stars represent kidney.)
ABLE E1. Comparison of myocardial infarction area and heart function before (Pre) and after (Post) cell or medium
njection
Group 1 Group 2 Group 3 Group 4
Pre Post Pre Post Pre Post Pre Post
I area (cm2) 6.5  2.1 6.4  2.3 6.4  1.9 6.2  2.6 6.5  2.5 6.3  2.5 6.4  2.6 6.4  2.4
VEDV (mL) 56.8 5.3 65.2  5.2 54.8 6.8 63.2  3.7 57.4  4.3 60.2  4.7 56.8 2.8 62.2  4.4
VESV (mL) 33.5 7.6 37.3  5.6 32.3 5.3 36.3  6.9 33.5  3.6 34.3  5.4 32.7 4.6 36.3  8.1
VEF (%) 42.3 7.2 44.5  8.7 41.7 6.8 43.1  7.4 41.8  8.6 42.8  5.6 42.7 7.7 43.3  8.4I, Myocardial infarction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction.
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